CellaVision Management

Management criteria checks 2/4

CellaVision's CEO is Simon Ostergaard, appointed in Mar 2021, has a tenure of 3.75 years. directly owns 0.021% of the company’s shares, worth SEK1.10M. The average tenure of the management team and the board of directors is 3.8 years and 3.9 years respectively.

Key information

Simon Ostergaard

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.8yrs
CEO ownership0.02%
Management average tenure3.8yrs
Board average tenure3.9yrs

Recent management updates

Recent updates

Does CellaVision (STO:CEVI) Have A Healthy Balance Sheet?

Nov 20
Does CellaVision (STO:CEVI) Have A Healthy Balance Sheet?

CellaVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Oct 27
CellaVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

CellaVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Jul 24
CellaVision AB (publ) Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Is CellaVision (STO:CEVI) A Risky Investment?

Jun 07
Is CellaVision (STO:CEVI) A Risky Investment?

Does CellaVision (STO:CEVI) Deserve A Spot On Your Watchlist?

May 22
Does CellaVision (STO:CEVI) Deserve A Spot On Your Watchlist?

CellaVision (STO:CEVI) Is Due To Pay A Dividend Of SEK2.25

Apr 13
CellaVision (STO:CEVI) Is Due To Pay A Dividend Of SEK2.25

CellaVision AB (publ)'s (STO:CEVI) Intrinsic Value Is Potentially 46% Above Its Share Price

Apr 09
CellaVision AB (publ)'s (STO:CEVI) Intrinsic Value Is Potentially 46% Above Its Share Price

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Mar 28
CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

CellaVision's (STO:CEVI) Dividend Will Be SEK2.25

Mar 14
CellaVision's (STO:CEVI) Dividend Will Be SEK2.25

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Feb 29
CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

After Leaping 28% CellaVision AB (publ) (STO:CEVI) Shares Are Not Flying Under The Radar

Feb 16
After Leaping 28% CellaVision AB (publ) (STO:CEVI) Shares Are Not Flying Under The Radar

CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Feb 12
CellaVision (STO:CEVI) Will Pay A Dividend Of SEK2.25

Earnings Beat: CellaVision AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Feb 10
Earnings Beat: CellaVision AB (publ) Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

CellaVision's (STO:CEVI) Returns On Capital Not Reflecting Well On The Business

Dec 13
CellaVision's (STO:CEVI) Returns On Capital Not Reflecting Well On The Business

Is Now An Opportune Moment To Examine CellaVision AB (publ) (STO:CEVI)?

Sep 14
Is Now An Opportune Moment To Examine CellaVision AB (publ) (STO:CEVI)?

Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)

Aug 22
Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)

CellaVision (STO:CEVI) Is Reinvesting At Lower Rates Of Return

Jun 17
CellaVision (STO:CEVI) Is Reinvesting At Lower Rates Of Return

CellaVision's (STO:CEVI) Upcoming Dividend Will Be Larger Than Last Year's

May 07
CellaVision's (STO:CEVI) Upcoming Dividend Will Be Larger Than Last Year's

Estimating The Fair Value Of CellaVision AB (publ) (STO:CEVI)

Apr 19
Estimating The Fair Value Of CellaVision AB (publ) (STO:CEVI)

CellaVision (STO:CEVI) Is Increasing Its Dividend To SEK2.25

Apr 05
CellaVision (STO:CEVI) Is Increasing Its Dividend To SEK2.25

CellaVision (STO:CEVI) Is Paying Out A Larger Dividend Than Last Year

Mar 04
CellaVision (STO:CEVI) Is Paying Out A Larger Dividend Than Last Year

CellaVision AB (publ) (STO:CEVI) Analysts Are More Bearish Than They Used To Be

Feb 11
CellaVision AB (publ) (STO:CEVI) Analysts Are More Bearish Than They Used To Be

Is CellaVision (STO:CEVI) A Risky Investment?

Jan 13
Is CellaVision (STO:CEVI) A Risky Investment?

Is CellaVision AB (publ) (STO:CEVI) Potentially Undervalued?

Dec 13
Is CellaVision AB (publ) (STO:CEVI) Potentially Undervalued?

CellaVision (STO:CEVI) Seems To Use Debt Rather Sparingly

Sep 23
CellaVision (STO:CEVI) Seems To Use Debt Rather Sparingly

CellaVision (STO:CEVI) May Have Issues Allocating Its Capital

Aug 16
CellaVision (STO:CEVI) May Have Issues Allocating Its Capital

Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)

Aug 02
Calculating The Intrinsic Value Of CellaVision AB (publ) (STO:CEVI)

We Ran A Stock Scan For Earnings Growth And CellaVision (STO:CEVI) Passed With Ease

Jun 27
We Ran A Stock Scan For Earnings Growth And CellaVision (STO:CEVI) Passed With Ease

What Is CellaVision AB (publ)'s (STO:CEVI) Share Price Doing?

May 31
What Is CellaVision AB (publ)'s (STO:CEVI) Share Price Doing?

CEO

Simon Ostergaard (53 yo)

3.8yrs

Tenure

Mr. Simon Ostergaard has been the Chief Executive Officer and President at CellaVision AB (publ) since March 21, 2021. He has broad experience is primarily in CellaVision's adjacent area of pathology and o...


Leadership Team

NamePositionTenureCompensationOwnership
Christer Fahraeus
Founder & Directorno dataSEK 285.00k6.83%
SEK 359.9m
Simon Ostergaard
CEO & President3.8yrsno data0.021%
SEK 1.1m
Magnus Blixt
Chief Financial Officer11.6yrsno data0.017%
SEK 884.0k
Adele Horn
Corporate Communications & Investor Relations Managerno datano datano data
Peter Wilson
Vice President of Business Development & Global Marketingno datano data0.013%
SEK 663.1k
Urban Strindlov
Vice President of Global Sales2.9yrsno datano data
Nina Wallander
Vice President of Human Resources3.9yrsno datano data

3.8yrs

Average Tenure

57.5yo

Average Age

Experienced Management: CEVI's management team is considered experienced (3.8 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Christer Fahraeus
Founder & Director30.9yrsSEK 285.00k6.83%
SEK 359.9m
Mikael Worning
Independent Chairman of the Board4.9yrsSEK 800.00k0.0099%
SEK 521.3k
Stefan Wolf
Independent Director6.6yrsSEK 260.00kno data
Ann-Charlotte Jarleryd
Independent Director2.6yrsSEK 360.00kno data
Kent Strahlen
Independent Employee Representative Director2.9yrsno data0.0042%
SEK 220.9k
Louise Armstrong-Denby
Independent Director1.6yrsSEK 130.00kno data

3.9yrs

Average Tenure

58.5yo

Average Age

Experienced Board: CEVI's board of directors are considered experienced (3.9 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 18:39
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CellaVision AB (publ) is covered by 10 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sten GustafssonABG Sundal Collier
Bjorn RydellABG Sundal Collier Sponsored
Carl-Oscar BredengenBerenberg